Aberrant Detergent-Insoluble Excitatory Amino Acid Transporter 2 Accumulates in Alzheimer Disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1097/NEN.0b013e3181e24adbPMID 20535038PMCID PMC3097122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.

  2009cited by this paper
• Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling

  2009cited by this paper
• Detergent‐Insoluble EAAC1/EAAT3 Aberrantly Accumulates in Hippocampal Neurons of Alzheimer's Disease Patients

  2009cited by this paper
• Quantitation and Mapping of Cerebral Detergent‐Insoluble Proteins in the Elderly

  2009cited by this paper
• A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2).

  2008cited by this paper
• Alzheimer disease and the role of free radicals in the pathogenesis of the disease.

  2008cited by this paper
• Pyrrolidine Dithiocarbamate Activates Akt and Improves Spatial Learning in APP/PS1 Mice without Affecting β-Amyloid Burden

  2007cited by this paper
• Pathologically activated therapeutics for neuroprotection

  2007cited by this paper
• Extracellular Glutamate Concentration in Hippocampal Slice

  2007cited by this paper
• Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

  2007cited by this paper
• Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

  2007cited by this paper
• Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse

  2006cited by this paper
• Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice.

  2006cited by this paper
• Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

  2006cited by this paper
• Glial glutamate transporter expression patterns in brains from multiple mammalian species

  2005cited by this paper
• Proteomic determination of widespread detergent insolubility, including Aβ but not tau, early in the pathogenesis of Alzheimer's disease

  2005cited by this paper
• Discovering statistics using SPSS, 2nd ed.

  2005cited by this paper
• Structure of a glutamate transporter homologue from Pyrococcus horikoshii

  2004cited by this paper
• Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters.

  2004cited by this paper
• The Glutamate Transporter GLT1a Is Expressed in Excitatory Axon Terminals of Mature Hippocampal Neurons

  2004cited by this paper
• Glutamate uptake determines pathway specificity of long-term potentiation in the neural circuitry of fear conditioning.

  2004cited by this paper
• Presenilin‐1 and intracellular calcium stores regulate neuronal glutamate uptake

  2004cited by this paper
• Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex.

  2003cited by this paper
• Statistical Principles in Experimental Design

  2003cited by this paper
• Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer's disease.

  2002cited by this paper
• Inhibition of glial glutamate transporter GLT-1 augments brain edema after transient focal cerebral ischemia in mice.

  2002cited by this paper
• Aberrant Expression of the Glutamate Transporter Excitatory Amino Acid Transporter 1 (EAAT1) in Alzheimer's Disease

  2002cited by this paper
• The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

  2001cited by this paper
• Glutamate uptake.

  2001cited by this paper
• Discovering Statistics Using SPSS

  2000cited by this paper
• Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice.

  2000cited by this paper
• Beneficial Effects of Dietary Restriction on Cerebral Cortical Synaptic Terminals

  2000cited by this paper
• Neurotrophic factors protect cortical synaptic terminals against amyloid and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function.

  2000cited by this paper
• Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice

  1998cited by this paper
• Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?

  1998cited by this paper
• The Number of Glutamate Transporter Subtype Molecules at Glutamatergic Synapses: Chemical and Stereological Quantification in Young Adult Rat Brain

  1998cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Neuronal and Glial Glutamate Transporters Possess an SH‐based Redox Regulatory Mechanism

  1997cited by this paper
• 17β‐Estradiol attenuates oxidative impairment of synaptic Na+/K+‐ATPase activity, glucose transport, and glutamate transport induced by amyloid β‐peptide and iron

  1997cited by this paper
• Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories: concurrences and cautions.

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

  1997cited by this paper
• Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.

  1997cited by this paper
• Neurodegenerative disorders with extensive tau pathology: A comparative study and review

  1996cited by this paper
• Brain Glutamate Transporter Proteins Form Homomultimers*

  1996cited by this paper
• Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain.

  1996cited by this paper
• Peroxynitrite Inhibits Glutamate Transporter Subtypes (*)

  1996cited by this paper
• Quantification of presenilin‐1 mRNA in Alzheimer's disease brains

  1996cited by this paper
• Amyloid β Peptide (25–35) Inhibits Na+‐Dependent Glutamate Uptake in Rat Hippocampal Astrocyte Cultures

  1996cited by this paper
• Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease.

  1996cited by this paper
• β-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease

  1995cited by this paper
• beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease.

  1995cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• Statistical Principles in Experimental Design

  1963cited by this paper

• Computational Based Identified EAAT2 Transporter Activator Attenuates Amyloid‐β Induced Excitotoxicity in Primary Neuronal‐Astroglial Mixed Culture by Ameliorating Glutamate Clearance

  2026cites this paper
• Aspartate in the Brain: A Review

  2025cites this paper
• Impact of Manganese on Neuronal Function: An Exploratory MultiOmic Study on Ferroalloy Workers in Brescia, Italy

  2025cites this paper
• Medical and Nonmedical Applications of Synthetic Transmembrane Anion Transporters

  2025cites this paper
• Astrocyte and oligodendrocyte pathology in Alzheimer's disease

  2025cites this paper
• Ceftriaxone attenuates Poly I:C–induced neuroinflammation in vitro by modulating glutamate transport, synaptic integrity, and immunometabolic reprogramming

  2025cites this paper
• Impact of Manganese on Neuronal Function: An Exploratory Multi-Omics Study on Ferroalloy Workers in Brescia, Italy

  2025cites this paper
• The NMDAR/TRPM4 death complex is a major promoter of disease progression in the 5xFAD mouse model of Alzheimer’s disease

  2025cites this paper
• The glutamatergic system in Alzheimer’s disease: a systematic review with meta-analysis

  2024cites this paper
• PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease

  2024cites this paper
• Sulbactam protects neurons against double neurotoxicity of amyloid beta and glutamate load by upregulating glial glutamate transporter 1

  2024cites this paper
• Hybrid virtual screening and molecular dynamics approach for identification of allosteric modulator of EAAT2

  2024cites this paper
• A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases

  2023cites this paper
• PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease

  2023cites this paper
• Exposure to environmental airborne particulate matter caused wide-ranged transcriptional changes and accelerated Alzheimer's-related pathology: A mouse study.

  2023cites this paper
• Patterns of gene expression and allele-specific expression vary among macular tissues and clinical stages of Age-related Macular Degeneration

  2023cites this paper
• Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease?

  2023cites this paper
• The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review

  2022influential citation
• Se-Methylselenocysteine (SMC) Improves Cognitive Deficits by Attenuating Synaptic and Metabolic Abnormalities in Alzheimer's Mice Model: A Proteomic Study.

  2021cites this paper
• NMDAR-dependent somatic potentiation of synaptic inputs is correlated with β amyloid-mediated neuronal hyperactivity

  2021cites this paper
• Sequence of proteome profiles in preclinical and symptomatic Alzheimer's disease

  2021cites this paper
• Utilizing an Animal Model to Identify Brain Neurodegeneration-Related Biomarkers in Aging

  2021cites this paper
• The Role of the SLC Transporters Protein in the Neurodegenerative Disorders

  2020cites this paper
• A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer’s brain

  2020cites this paper
• Positive allosteric activation of glial EAAT-2 transporter protein: A novel strategy for Alzheimer's disease.

  2020cites this paper
• Sex-dependent impaired locomotion and motor coordination in the HdhQ200/200 mouse model of Huntington's Disease.

  2019cites this paper
• Contribution of astrocytes to metabolic dysfunction in the Alzheimer’s disease brain

  2019cites this paper
• Chronic hyperammonemia alters extracellular glutamate, glutamine and GABA and membrane expression of their transporters in rat cerebellum. Modulation by extracellular cGMP.

  2019cites this paper
• The solute carrier transporters and the brain: Physiological and pharmacological implications

  2019cites this paper
• Drugs to Alter Extracellular Concentration of Glutamate: Modulators of Glutamate Uptake Systems

  2018cites this paper
• Altered expression of glutamate transporter‐1 and water channel protein aquaporin‐4 in human temporal cortex with Alzheimer's disease

  2018cites this paper
• Glutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies

  2018cites this paper
• Deciphering the Astrocyte Reaction in Alzheimer’s Disease

  2018cites this paper
• Novel interaction between Alzheimer’s disease-related protein presenilin 1 and glutamate transporter 1

  2018cites this paper
• Reactive Astrocytes as Drug Target in Alzheimer's Disease

  2018cites this paper
• Circadian Regulation of Glutamate Transporters

  2018cites this paper
• Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review

  2018cites this paper
• Ceftriaxone Improves Cognitive Function and Upregulates GLT-1-Related Glutamate-Glutamine Cycle in APP/PS1 Mice

  2018cites this paper
• Biochemical Approaches for Glutamatergic Neurotransmission

  2018cites this paper
• Message from the Centre Director

  2018cites this paper
• Modulation de la réactivité astrocytaire par ciblage de la voie JAK2-STAT3 : conséquences dans des modèles murins de la maladie d’Alzheimer

  2017cites this paper
• Amyloid-beta peptide decreases expression and function of glutamate transporters in nervous system cells.

  2017cites this paper
• Diversity of astroglial responses across human neurodegenerative disorders and brain aging

  2017influential citation
• Generation of Defined Astrocytic Phenotypesfrom Human Pluripotent Stem Cellsfor Transplantation after Spinal Cord Injury

  2017cites this paper
• Astrocytic transporters in Alzheimer's disease.

  2017cites this paper
• Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging

  2016cites this paper
• Peripheral Interventions Enhancing Brain Glutamate Homeostasis Relieve Amyloid &bgr;- and TNF&agr;- Mediated Synaptic Plasticity Disruption in the Rat Hippocampus

  2016cites this paper
• Glial Cells - The Key Elements of Alzheimer´s Disease.

  2016cites this paper
• The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease

  2016cites this paper
• SK3 Channel Overexpression in Mice Causes Hippocampal Shrinkage Associated with Cognitive Impairments

  2016cites this paper
• Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease

  2015cites this paper
• Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.

  2015cites this paper
• Current approaches to enhance glutamate transporter function and expression

  2015cites this paper
• The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease.

  2015cites this paper
• Elusive roles for reactive astrocytes in neurodegenerative diseases

  2015influential citation
• SLC transporters as therapeutic targets: emerging opportunities

  2015cites this paper
• Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice

  2015cites this paper
• Proteomics of protein post-translational modifications implicated in neurodegeneration

  2014cites this paper
• GLT-1 transporter: an effective pharmacological target for various neurological disorders.

  2014cites this paper
• iTRAQ quantitative clinical proteomics revealed role of Na(+)K(+)-ATPase and its correlation with deamidation in vascular dementia.

  2014cites this paper
• Genetics of essential tremor: from phenotype to genes, insights from both human and mouse studies.

  2014cites this paper
• Emerging roles for glial pathology in addiction

  2014cites this paper
• Genome scan in familial late‐onset Alzheimer's disease: A locus on chromosome 6 contributes to age‐at‐onset

  2013cites this paper
• Amyloid-β1–42 Slows Clearance of Synaptically Released Glutamate by Mislocalizing Astrocytic GLT-1

  2013cites this paper
• Riluzole Partially Rescues Age-Associated, but not LPS-Induced, Loss of Glutamate Transporters and Spatial Memory

  2013cites this paper
• 4-Hydroxyhexenal (HHE) Impairs Glutamate Transport in Astrocyte Cultures

  2012cites this paper
• The Rates of Postmortem Proteolysis of Glutamate Transporters Differ Dramatically between Cells and between Transporter Subtypes

  2012cites this paper
• Differential Expression of the Glutamate Transporter GLT-1 in Pancreas

  2012influential citation
• Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease

  2012cites this paper
• GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer's Disease Animal Model

  2011cites this paper